Let’s dive into the numbers:
Revenue: ₹57.4 crore, up only 0.7% YoY — a modest gain in a competitive landscape.
Recurring PAT: ₹57.4 crore, up 5.4% YoY, beating estimates by 15.2%, thanks to tighter cost control.
Gross Margin: 46.8%, down 205 bps YoY due to a weaker mix and higher trade discounts.
Management sees a sequential demand uptick ahead, supported by initiatives like A&P cuts and logistics optimization.
Looking ahead, the company expects:
While the competitive intensity remains a challenge, Indigo Paints is focusing on core cost management and product positioning to protect margins.
The main challenges remain:
Metric | Q4FY25 Highlights |
---|---|
Revenue | ₹57.4 crore (+0.7% YoY) |
Recurring PAT | ₹57.4 crore (+5.4% YoY,15.2% beat) |
Gross Margin | 46.8% (↓205 bps YoY) |
FY26E Earnings | ↓ 7.2% expected |
FY27E Earnings | +12.4% expected |
P/E (FY27E EPS) | 33.6x |
Revised Fair Value | ₹1,000 (down from prior) |
Particular | Details |
---|---|
CMP | ₹1045 |
Target Price | ₹1000 |
Rating | REDUCE |
Indigo Paints is navigating a patchy demand backdrop and a rise in competitive intensity. While recurring profitability showed some resilience in Q4, cautious near-term outlook and expensive valuations keep the call at REDUCE.
This feature is based on a synopsis of a research report issued by Kotak Securities Limited. For the full story (and disclaimers), make sure to check out the original sources:
Investments in securities market are subject to market risks, read all the related documents carefully before investing. This information is purely backed by KSL research analyst based on research recommendation. Kotak Securities Ltd has registration granted by SEBI, Enlistment as RA and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors. Registered Office: 27 BKC, C 27, G Block, Bandra Kurla Complex, Bandra (E), Mumbai 400051. SEBI Registration No. INZ000200137 (Member of NSE, BSE, MSE, MCX & NCDEX), Member Id: NSE-08081; BSE-673; MSE-1024; MCX-56285; NCDEX-1262. Research Analyst INH000000586; BSE Enlistment No: 5035 for compliance T&C and disclaimers, Visit https://ddei5-0-ctp.trendmicro.com:443/wis/clicktime/v1/query?url=https%3a%2f%2fbit.ly%2flongdisc&umid=818E14E7-34FE-7906-906B-8F0B1C42A394&auth=d2c41a7df2e2ef1fca42bbbefb1c825d24cf1548-36f3d1caa4f5ef82b030dac05eca909befcec775,